Kircik L, Lebwohl M, Papp K, Gooderham M, Stein Gold L, Draelos Z, Kempers S, Tyring S, Albrecht L, Wiseman M, Ferris L, Smith K, Higham R, Navale L, Welgus H, Berk D. Roflumilast Cream (ARQ-151) 0.15% and 0.3% Improved Burden of Signs and Symptoms in Adults With Chronic Plaque Psoriasis in a Phase 2b Study. J of Skin [Internet]. 2020Oct.27 [cited 2022Aug.15];4(6):s70. Available from: https://jofskin.org/index.php/skin/article/view/1103